| Dr Thomas Edward Noonan, OD | |
|
1040 Barnum Ave, Stratford, CT 06614-4968 | |
| (203) 378-3113 | |
| (203) 377-7207 |
| Full Name | Dr Thomas Edward Noonan |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 41 Years |
| Location | 1040 Barnum Ave, Stratford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104960384 | NPI | - | NPPES |
| 004081907 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1009 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stratford Eyecare Associates Llc | 3375673809 | 2 |
News Archive
HealthcarePays has created a virtual card processing solution to ensure compliance, reconciliation of remittance information with payments, and detection of waste and fraud for healthcare providers throughout the United States. MasterCard will supply the connection between banks and providers to ensure speed and convenience in the payment process.
The environmental context in which addicts experience the rewarding effects of cocaine can readily elicit cocaine-associated memories. These memories persist long after abstinence and trigger cocaine-craving and consumption.
Northwestern Medicine researchers are co-investigators in a breakthrough clinical trial that found transplanted human islets prevent hypoglycemic events and provide excellent glycemic control for patients with Type 1 diabetes with severe hypoglycemia. The results of the multi-center, single arm, phase III study are published in Diabetes Care on Monday, April 18. The research was funded by National Institute of Health grants through the National Institute of Allergy and Infectious Diseases and the National Institute for Diabetes and Digestive and Kidney Disease.
Researchers from City of Hope, a world-renowned comprehensive cancer center and independent biomedical research institution, have developed a synthetic DNA molecule that is programmed to jump-start the immune system to eradicate genetically distinct types of prostate cancer.
BioSante Pharmaceuticals, Inc., announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects.
› Verified 2 days ago
| Provider Name | Stratford Eyecare Associates Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1295866242 PECOS PAC ID: 3375673809 Enrollment ID: O20100610000298 |
News Archive
HealthcarePays has created a virtual card processing solution to ensure compliance, reconciliation of remittance information with payments, and detection of waste and fraud for healthcare providers throughout the United States. MasterCard will supply the connection between banks and providers to ensure speed and convenience in the payment process.
The environmental context in which addicts experience the rewarding effects of cocaine can readily elicit cocaine-associated memories. These memories persist long after abstinence and trigger cocaine-craving and consumption.
Northwestern Medicine researchers are co-investigators in a breakthrough clinical trial that found transplanted human islets prevent hypoglycemic events and provide excellent glycemic control for patients with Type 1 diabetes with severe hypoglycemia. The results of the multi-center, single arm, phase III study are published in Diabetes Care on Monday, April 18. The research was funded by National Institute of Health grants through the National Institute of Allergy and Infectious Diseases and the National Institute for Diabetes and Digestive and Kidney Disease.
Researchers from City of Hope, a world-renowned comprehensive cancer center and independent biomedical research institution, have developed a synthetic DNA molecule that is programmed to jump-start the immune system to eradicate genetically distinct types of prostate cancer.
BioSante Pharmaceuticals, Inc., announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Edward Noonan, OD 1040 Barnum Ave, Stratford, CT 06614-4968 Ph: (203) 378-3113 | Dr Thomas Edward Noonan, OD 1040 Barnum Ave, Stratford, CT 06614-4968 Ph: (203) 378-3113 |
News Archive
HealthcarePays has created a virtual card processing solution to ensure compliance, reconciliation of remittance information with payments, and detection of waste and fraud for healthcare providers throughout the United States. MasterCard will supply the connection between banks and providers to ensure speed and convenience in the payment process.
The environmental context in which addicts experience the rewarding effects of cocaine can readily elicit cocaine-associated memories. These memories persist long after abstinence and trigger cocaine-craving and consumption.
Northwestern Medicine researchers are co-investigators in a breakthrough clinical trial that found transplanted human islets prevent hypoglycemic events and provide excellent glycemic control for patients with Type 1 diabetes with severe hypoglycemia. The results of the multi-center, single arm, phase III study are published in Diabetes Care on Monday, April 18. The research was funded by National Institute of Health grants through the National Institute of Allergy and Infectious Diseases and the National Institute for Diabetes and Digestive and Kidney Disease.
Researchers from City of Hope, a world-renowned comprehensive cancer center and independent biomedical research institution, have developed a synthetic DNA molecule that is programmed to jump-start the immune system to eradicate genetically distinct types of prostate cancer.
BioSante Pharmaceuticals, Inc., announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects.
› Verified 2 days ago
Sean West, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 775 Main St, Stratford, CT 06615 Phone: 203-377-2020 Fax: 203-381-9936 | |
Dr. Arnold A. Cummins, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 150 Barnum Avenue Cutoff, Walmart Vision Center, Stratford, CT 06614 Phone: 203-656-1445 | |
Stratford Eyecare Associates, L.l.c. Optometrist Medicare: Medicare Enrolled Practice Location: 1040 Barnum Ave, Stratford, CT 06614 Phone: 203-378-2269 Fax: 203-377-7207 | |
Ms. Lorraine J Fedyna, OD Optometrist Medicare: Medicare Enrolled Practice Location: 955 Ferry Blvd, Stratford, CT 06614 Phone: 203-375-7988 Fax: 203-375-7989 | |
Dr. Helen Ambizas, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 775 Main St, Stratford, CT 06615 Phone: 203-377-2020 | |
Dr. Aylin Adem, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 411 Barnum Avenue Cutoff Ste 9, Stratford, CT 06615 Phone: 475-236-3013 |